ATRY — Atrys Health SA Cashflow Statement
0.000.00%
Last trade - 00:00- €213.30m
- €453.50m
- €141.01m
Annual cashflow statement for Atrys Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.9 | -24.7 | -33.7 | -33.5 | -56.2 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 18.7 | 7.45 | 34 | 34.1 | 47.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.9 | -28.5 | -28 | -26.7 | -20.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.69 | -15.4 | 5.7 | 3 | -1.56 |
| Capital Expenditures | -8.57 | -15.2 | -13.1 | -13.1 | -12.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 6.12 | -65.4 | 13.5 | 0.185 | -0.074 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.45 | -80.6 | 0.395 | -13 | -12.6 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.1 | 94.8 | 1.4 | -11.5 | 11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.6 | -0.831 | 7.53 | -21.5 | -2.87 |